Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Latest filing published 06 Mar 2023 for Aurinia Pharmaceuticals Inc.. Read the official filing
Filing timeline
BuySaleMichael Robert Martin
Insider track record
Disclosed buys
1
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+77.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Michael Robert Martin: trading record in brief
Michael Robert Martin is a declared insider of Aurinia Pharmaceuticals Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 14 filings cover trades dated from 11 May 2021 to 2 March 2023.
Both buying and selling appear: 1 purchase worth €156k, against 6 sales worth €1.9M. Sales outweigh purchases by €1.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants and 5 option exercises.
The record was last updated on 6 March 2023 with a share grant in Aurinia Pharmaceuticals Inc. The last insider purchase was made public on 9 November 2022, 1,439 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Robert Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
107,202 sharesCommon StockSEC:0001628280-23-006529:0
30,000 shares@ US$5.163.0% of flowCommon StockSEC:0001628280-22-029215:0
Canonical exit: 5 Feb 2023 (T+90)
8,500 shares0Common StockSEC:0001628280-22-005130:0
50,000 shares@ US$30.1748.0% of flowCommon SharesSEC:0001628280-21-023169:0
45,000 shares@ US$3.204.6% of flowCommon StockSEC:0001628280-21-021477:0
28,500 shares@ US$5.304.8% of flowCommon StockSEC:0001628280-21-019048:0
44,000 shares@ US$5.307.3% of flowCommon StockSEC:0001628280-21-018782:0
25,000 shares@ US$5.304.1% of flowCommon SharesSEC:0001628280-21-018603:0
7,500 shares@ US$18.104.2% of flowCommon StockSEC:0001628280-21-018219:0
22,500 shares@ US$17.8112.6% of flowCommon StockSEC:0001628280-21-017720:0
5,000 shares@ US$16.012.5% of flowCommon StockSEC:0001628280-21-016403:0
5,000 shares@ US$13.862.2% of flowCommon StockSEC:0001628280-21-014882:0
5,000 shares@ US$13.762.1% of flowCommon StockSEC:0001628280-21-012730:0
20,000 shares@ US$3.021.8% of flowCommon StockSEC:0001628280-21-010021:0
14 of 14 declarations
